A carregar...
Comparison of futility monitoring guidelines using completed phase III oncology trials
BACKGROUND: Futility (inefficacy) interim monitoring is an important component in the conduct of phase III clinical trials, especially in life threatening diseases. Desirable futility monitoring guidelines allow timely stopping if the new therapy is harmful or if it is unlikely to demonstrate to be...
Na minha lista:
| Publicado no: | Clin Trials |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5300958/ https://ncbi.nlm.nih.gov/pubmed/27590208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774516666502 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|